Kelly Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Kelly Financial Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-66	Closed	-$1.55K	–	153
2024 Q2	$1.55K	Hold	66	–	–	﹤0.01%	615
2024 Q1	$1.9K	Hold	66	–	–	﹤0.01%	607
2023 Q4	$2.17K	Hold	66	–	–	﹤0.01%	572
2023 Q3	$1.84K	Hold	66	–	–	﹤0.01%	554
2023 Q2	$2.25K	Hold	66	–	–	﹤0.01%	539
2023 Q1	$1.99K	Hold	66	–	–	﹤0.01%	528
2022 Q4	$1.86K	Hold	66	–	–	﹤0.01%	513
2022 Q3	$2.17K	Hold	66	–	–	﹤0.01%	493
2022 Q2	$2.08K	Hold	66	–	–	﹤0.01%	496
2022 Q1	$3.03K	Hold	66	–	–	﹤0.01%	482
2021 Q4	$4.04K	Buy	+66	New	+$4.56K	﹤0.01%	470

Other funds holding ARKG

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Kelly Financial Services's ARKG Position: Q3 2024 in Review

Kelly Financial Services sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 66 shares — an estimated $1.55K sold.

Kelly Financial Services first reported a position in ARKG in Q4 2021 and held it in 11 quarters. The position peaked at $4.04K in Q4 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

Kelly Financial Services reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
Kelly Financial Services sold 66 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $1.55K.
Kelly Financial Services first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 11 quarters.
Kelly Financial Services's ARK Genomic Revolution ETF position peaked at $4.04K in Q4 2021.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.